FRAZER, PA US

1. 20110044979 DOMAIN ANTIBODY CONSTRUCT - which binds to human TNF 02-24-2011
2. 20110038860 METHODS FOR INHIBITION OF POLYCLONAL B CELL ACTIVATION AND IMMUNOGLOBULIN CLASS SWITCHING TO PATHOGENIC AUTOANTIBODIES BY BLOCKING CD1-MEDIATED INTERACTIONS 02-17-2011
3. 20110021583 ENHANCED TRANSMUCOSAL COMPOSITION AND DOSAGE FORM 01-27-2011
4. 20100311752 Substituted pyridazine derivatives - compounds having histamine H 12-09-2010
5. 20100298332 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands 11-25-2010
6. 20100297134 HUMANISED ANTIBODIES WITH ANTI-TUMOUR ACTIVITY 11-25-2010
7. 20100280007 Pyridazinone Derivatives - novel pyridizinone derivatives that mediate enzymatic activity 11-04-2010
8. 20100273779 Pyridazinone Derivatives - novel pyridizinone derivatives that mediate enzymatic activity 10-28-2010
9. 20100210731 Modafinil Compositions - Polymorphs and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and discussed 08-19-2010
10. 20100210701 Novel Forms of Bendamustine Free Base - Novel polymorphic forms of bendamustine free base are described including amorphous bendamustine free base 08-19-2010
11. 20100152196 Novel Fused Pyrrolocarbazoles - generally to selected fused pyrrolocarbazoles including pharmaceutical compositions thereof and methods of treating 06-17-2010
12. 20100129444 Novel Pharmaceutical Formulations of Modafinil 05-27-2010
13. 20100121055 PROCESSES FOR PREPARING (R)-2-METHYLPYRROLIDINE AND (S)-2-METHYLPYRROLIDINE AND TARTRATE SALTS THEREOF 05-13-2010
14. 20100112045 SURFACE-TREATED MODAFINIL PARTICLES - solid oral dosage forms comprising surface-treated particles comprising modafinil particles and a hydrophilic 05-06-2010
15. 20100111902 COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES 05-06-2010
16. 20100080829 LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME 04-01-2010
17. 20100048720 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 02-25-2010
18. 20100048719 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 02-25-2010
19. 20100048718 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 02-25-2010
20. 20100048576 PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS 02-25-2010
21. 20100022653 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 01-28-2010
22. 20090317481 MODAFINIL FORMULATIONS - oral pharmaceutical composition comprising modafinil particles wherein at least about 5% of said modafinil particles have a 12-24-2009
23. 20090291918 PROTEASOME INHIBITORS AND METHODS OF USING THE SAME 11-26-2009
24. 20090281193 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 11-12-2009
25. 20090281192 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil 11-12-2009
26. 20090264488 NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE 10-22-2009
27. 20090221555 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS 09-03-2009
28. 20090214442 Oral Transmucosal Nicotine Dosage Form - Described herein are oral transmucosal solid dosage forms useful in treating nicotine addiction or as a 08-27-2009
29. 20090202632 Sublingual Buccal Effervescent - pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal sublingual or gingival 08-13-2009
30. 20090186888 NOVEL FUSED PYRROLOCARBAZOLES - generally to selected fused pyrrolocarbazoles including pharmaceutical compositions thereof and methods of treating 07-23-2009
31. 20090155352 Microemulsion containing indolocarbazole compound and dosage forms containing the same 06-18-2009
32. 20090105241 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES 04-23-2009
33. 20090075936 Proteasome inhibitors and methods of using the same 03-19-2009
34. 20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives 03-05-2009
35. 20090042907 Bicyclic aromatic sulfinyl derivatives - compounds of the structure: STR00001 wherein the constituent members are defined herein 02-12-2009
36. 20090018202 Modafinil compositions 01-15-2009
37. 20090018143 Thio-substituted arylmethanesulfinyl derivatives 01-15-2009
38. 20080311205 Abuse resistant drug formulation - pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical 12-18-2008
39. 20080287494 Transmucosal treatment methods in patients with mucositis 11-20-2008
40. 20080207761 Pharmaceutical formulations of modafinil 08-28-2008